Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dave Gore's Trades That Make Sense -- Ignore unavailable to you. Want to Upgrade?

To: Baton who wrote (1470)	1/28/2002 1:28:37 AM
From: Dave Gore	Read Replies (2) \| Respond to of 16631

STOCK ANALYSIS: DGX - adding to watchlist Overview courtesy of Baton: Dave: I've mentioned this one before - Quest Diagnostics (DGX). It is the largest lab test company in the US. If you have ever had blood or other tests disease related tests through your doctor, chances are that Quest did the actual test results. They are fairly recession proof since insurance companies pay the bulk of the test fees. They are growing in size and earnings and have made a couple of large, successful acquisitions. Clearstation: RS = 41 fairly poor, regularly breaks below the 13 day ema line and the 50 day line too. Looks to be running into earnings a bit, which raises a bit of a caution flag if they at all disappoint. Stochastics though are nowhere near oversold. MACD is very healthy and even notice how the horizontal line is closer to the bottom than the top. Bigcharts: B-bands = 66.50 to 74; 20 and 50-day support levels at 67 and 70. Money flow, momentum, and OBV are all positive but the OBV is trending toward flat, which is its worst reading in about 2 weeks. Conclusion: Would love to see this pullback to the 20 day line at $70 for an entry or better yet wait until after earnings for possible profit-taking and pullback. Stocks that have already run into earnings are less attractive.